| 1 |
34150160 | The effect of TACE in combination with thalidomide-mediated adjuvant therapy on the levels of VEGF and bFGF in patients with hepatocellular carcinoma. | 2021 |
4 |
| 2 |
28982338 | Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model. | 2018 |
1 |
| 3 |
24692723 | The influence of retinoic Acid and thalidomide on the radiosensitivity of u343 glioblastoma cells. | 2014 Apr |
1 |
| 4 |
25053990 | Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma. | 2014 Mar |
5 |
| 5 |
22098296 | Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide. | 2012 Jun |
2 |
| 6 |
20616958 | Anti-angiogenesis therapies: their potential in cancer management. | 2010 Jun 24 |
2 |
| 7 |
18671617 | Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma. | 2008 Aug |
1 |
| 8 |
18687660 | The G-rich promoter and G-rich coding sequence of basic fibroblast growth factor are the targets of thalidomide in glioma. | 2008 Aug |
5 |
| 9 |
17369076 | The thalidomide saga. | 2007 |
1 |
| 10 |
17597196 | A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study. | 2007 Sep |
1 |
| 11 |
17013434 | [Thalidomide in treatment of connective diseases and vasculities]. | 2006 Jul-Sep |
1 |
| 12 |
15086832 | Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment. | 2004 May |
3 |
| 13 |
15149630 | Response to thalidomide in multiple myeloma: impact of angiogenic factors. | 2004 May 21 |
1 |
| 14 |
15628770 | [A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP]. | 2004 Dec |
1 |
| 15 |
12644816 | An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer. | 2003 Mar 24 |
1 |
| 16 |
12736723 | Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells. | 2003 Jun |
2 |
| 17 |
12894531 | Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells. | 2003 May-Jun |
5 |
| 18 |
14558594 | Effects of thalidomide on parameters involved in angiogenesis: an in vitro study. | 2003 Sep |
2 |
| 19 |
11942970 | Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide. | 2002 Apr |
1 |
| 20 |
12358938 | Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF. | 2002 Oct |
1 |
| 21 |
11555579 | High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. | 2001 Sep |
1 |
| 22 |
11592764 | The treatment of advanced renal cell cancer with high-dose oral thalidomide. | 2001 Sep 28 |
2 |
| 23 |
10661908 | Hypothesis: thalidomide embryopathy-proposed mechanism of action. | 2000 Mar |
1 |
| 24 |
10799645 | Mechanism of action in thalidomide teratogenesis. | 2000 Jun 15 |
2 |
| 25 |
10849134 | Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus. | 2000 May |
1 |
| 26 |
11188934 | [Thalidomide. Clinical trials in cancer]. | 2000 |
1 |